Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1598351 | 0.85 | DNM1 (0.33) | BBOX1 | |
| SCHEMBL4902055 | 0.81 | CHRNB2 (0.34) | CHRM1CHRM3CHRM2 | |
| SCHEMBL758122 | 0.80 | CHRM5 (0.43) | CHRM4CHRM1CHRM3CHRM2 | |
| Hydrochloric Acid SCHEMBL2798096 | 0.79 | CHRNB2 (0.33) | CHRM1CHRM3CHRM2 | |
| Iodide SCHEMBL10787028 | 0.78 | CHRM5 (0.41) | CHRM4CHRM1CHRM3CHRM2 | |
| Hydrochloric Acid SCHEMBL366719 | 0.78 | CHRM5 (0.45) | CHRM4CHRM1CHRM3CHRM2 | |
| Bromide SCHEMBL366431 | 0.78 | GALR3 (0.45) | CHRM4CHRM1CHRM3CHRM2 | |
| SCHEMBL4051767 | 0.78 | DNM1 (0.35) | — | |
| SCHEMBL10452395 | 0.77 | CHRM1 (0.37) | CHRM4CHRM1CHRM3BBOX1CHRM2 | |
| SCHEMBL16674081 | 0.74 | CHRM1 (0.36) | CHRM4CHRM1CHRM3BBOX1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | UNIVERSITE DE MONTREAL (CA) | 2012-09-13 | — | — | US | disclosed |
| US-20110178306-A1 | Sulphonyl-1,2,4-Triazole Salts | PHOSTECH LITHIUM INC. (CA) | 2011-07-21 | — | — | US | disclosed |
| US-7919629-B2 | Sulphonyl-1,2,4-triazole salts | PHOSTECH LITHIUM INC. (CA) | 2011-04-05 | — | — | US | disclosed |
| US-20090292105-A1 | SULPHONYL-1,2,4-TRIAZOLE SALTS | PHOSTECH LITHIUM INC. (CA) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178306-A1 | Sulphonyl-1,2,4-Triazole Salts | TST, STS, SQOR | CHRM4 3045/4885CHRM1 3015/4885CHRM3 2096/4885 |
| US-20090292105-A1 | SULPHONYL-1,2,4-TRIAZOLE SALTS | TST, STS, SQOR | CHRM4 3045/4885CHRM1 3015/4885CHRM3 2096/4885 |
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | STS, TST, FIS1 | CHRM4 2430/4885CHRM1 2258/4885CHRM3 2126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.